Healthcare Services

Avian Flu Treatment Market Forecast Through 2030 Featuring Industry Drivers And Opportunities

May 27, 2026June 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Expected Market Value Outlook For The Avian Flu Treatment Market Through 2030?

The avian flu treatment market has experienced substantial growth in its size over recent years. It is anticipated to increase from $13.77 billion in 2025 to $15.04 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.3%. This historical expansion can be attributed to factors such as the rising occurrence of avian influenza outbreaks, the strategic use of antiviral stockpiling, government initiatives for disease control, the expansion of infectious disease treatment within hospitals, and heightened public health awareness.

The avian flu treatment market is projected to experience robust expansion over the coming years. By 2030, its value is anticipated to reach $20.6 billion, expanding at a compound annual growth rate (CAGR) of 8.2%. This anticipated growth during the forecast period stems from factors such as heightened investments in zoonotic disease research, the accelerating development of next-generation vaccines, an enlargement of global disease surveillance networks, a concentrated effort on swift response therapeutics, and strengthened international collaboration for pandemic readiness. Prominent trends identified for this period encompass the wider adoption of advanced antiviral therapies, an intensified focus on platforms for rapid vaccine development, the increasing application of monoclonal antibody treatments, the broadening of early diagnosis and surveillance initiatives, and an elevated emphasis on pandemic preparedness.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16352&type=smp

What Are The Main Drivers Accelerating The Growth Of The Avian Flu Treatment Market?

Increased awareness and improved diagnosis are projected to fuel the expansion of the avian flu treatment market in the coming period. Awareness refers to acknowledging a condition, whereas diagnosis involves pinpointing a particular problem stemming from that awareness. The imperative for avian flu treatment stems from the critical necessity to protect public health, avert potential pandemics, and shield poultry populations from substantial financial impacts. Effective avian flu treatment relies heavily on awareness and timely diagnosis, facilitating rapid intervention and containment measures to halt its dissemination. For example, according to the World Health Organization (WHO), a Switzerland-based intergovernmental body, in April 2024, over 8000 individuals in the US were under active observation between February 9, 2022, and March 29, 2024, following exposure to animals suspected of carrying the HPAI A (H5N1) virus. Consequently, the expanding awareness and improved diagnostic capabilities are propelling the growth within the avian flu treatment market.

What Are The Core Segment Classifications In The Avian Flu Treatment Market?

The avian flu treatment market covered in this report is segmented –

1) By Type: Vaccines, Antiviral Agents, Immunoglobulins

2) By Distribution Channel: Online Pharmacies, Offline Pharmacies

3) By End User: Hospital, Institutional Health Centers, Clinics

Subsegments:

1) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Subunit Vaccines, Dna Vaccines, Bivalent And Multivalent Vaccines

2) By Antiviral Agents: Neuraminidase Inhibitors (Oseltamivir, Zanamivir), Polymerase Inhibitors, Antiviral Combination Therapies

3) By Immunoglobulins: Human Immunoglobulin (Ivig), Monoclonal Antibodies, Hyperimmune Serum, Polyvalent Immunoglobulins, Avian Flu-Specific Immunoglobulins

Which Trends Are Contributing To Changes In The Avian Flu Treatment Market?

Leading entities within the avian flu treatment market are prioritizing the establishment of partnerships to improve effectiveness and accelerate the creation of novel therapies. These collaborations typically involve pharmaceutical firms, research organizations, and government bodies uniting to combine assets, exchange specialized knowledge, and conduct pioneering clinical studies. An illustrative example occurred in April 2024, when CureVac N.V., a biotechnology company based in Germany, collaborated with GSK plc, a pharmaceutical company from the UK, to develop an investigational influenza A (H5N1) pre-pandemic vaccine candidate. This initiative aims to counter the potential future pandemic danger presented by the H5N1 avian influenza virus. The objective of this joint venture is to assess the safety, reactogenicity, and immunogenicity of the monovalent vaccine candidate, which encodes an influenza A H5 antigen utilizing CureVac’s proprietary second-generation mRNA backbone. The integrated Phase 1/2 study will evaluate the vaccine candidate’s safety and efficacy among healthy adults ranging from 18 to 64 years old, as well as in older adults aged 65 to 85.

Which Industry Players Are Present In The Avian Flu Treatment Market?

Major companies operating in the avian flu treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline Plc, Novartis AG, AstraZeneca Plc, Gilead Sciences Inc., CSL Limited, Moderna Inc., Shionogi & Co. Ltd., Cipla Ltd., Seqirus, Novavax Inc., Sinovac Biotech Ltd., Valneva SE, CureVac AG, BioCryst Pharmaceuticals Inc., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Baxter International Inc., Takeda Pharmaceutical Company Limited

Access The Complete Avian Flu Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/avian-flu-treatment-global-market-report

Which Region Contributes The Most To The Avian Flu Treatment Market?

North America was the largest region in the avian flu treatment market in 2025. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the avian flu treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Avian Flu Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=16352&type=smp

Browse Through More Reports Similar to the Global Avian Flu Treatment Market 2026, By The Business Research Company

Influenza Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report

Swine Flu Vaccination Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/swine-flu-vaccination-global-market-report

Influenza Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795